Finsbury Worldwide Pharmaceutical Trust PLC
1 September 2009
Finsbury Worldwide Pharmaceutical Trust PLC
Voting Rights and Capital
In accordance with the Financial Services Authority's Disclosure and
Transparency Rules, Finsbury Worldwide Pharmaceutical Trust PLC announces the
following:
As at 31 August 2009, Finsbury Worldwide Pharmaceutical Trust PLC's capital
consists of ordinary shares of 25p, with each ordinary share holding one voting
right. The total number of ordinary shares in issue is 48,640,519. The Company
has 1,197,000 ordinary shares in Treasury.
Therefore, the total number of voting rights in Finsbury Worldwide
Pharmaceutical Trust PLC is 48,640,519.
The above figure (48,640,519) may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in Finsbury Worldwide Pharmaceutical Trust PLC, or a
change to their interest in Finsbury Worldwide Pharmaceutical Trust PLC, under
the Financial Services Authority's Disclosure and Transparency Rules.
- END -
Frostrow Capital LLP
Company Secretary
Tel: 0203 008 4913
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.